It will be interesting to see the look on Ikons face if Cellmid and Evolis get to 100 million in revenue in 7 years time as predicted by Colour Collective.
The look will be of realising what they could have been part of, far more than a paltry million.
And Soud, you have no idea how much is coming in this quarter from:
Evolis distribution into NM, BL and SS in the US all with strong sales growth and placing it into more stores,
Fillerina distribution hitherto uncounted in Australia,
Distribution into Japanese pharmacies which are in an already profitable market,
Sales through Ginza and distribution into China,
Million dollar day in November on QVC Japan with incoming revenues before the end of the quarter.
A distribution of Evolis and Fillerina in NZ
Nor do I but I suspect it may be substantial.
CDY Price at posting:
30.0¢ Sentiment: Buy Disclosure: Held
